A method of modulating cell survival, differentiation and/or synaptic plasticity

Details for Australian Patent Application No. 2004275929 (hide)

Owner ENKAM Pharmaceuticals A/S

Inventors Bock, Elisabeth; Soroka, Vladyslav; Berezin, Vladimir

Agent Peter Maxwell & Associates

Pub. Number AU-A-2004275929

PCT Pub. Number WO2005/030804

Priority pa 2003 01418 30.09.03 DK

Filing date 29 September 2004

Wipo publication date 7 April 2005

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

Event Publications

27 April 2006 PCT application entered the National Phase

  PCT publication WO2005/030804 Priority application(s): WO2005/030804

24 July 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004275937-Bicyclic imino acid derivatives used as inhibitors of matrix-metalloproteinases

2004275928-Melanocortin receptor agonists